MarketInOut Stock Screener Log In | Sign Up

Aditxt Inc

OTC • Healthcare • Biotechnology • Quote as of 10/30/2026
Aditxt Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeOTC
Market Capitalization0.998 mln
Float997 mln
Earnings Date11/18/2026

EPS

25,450,142
Exceptional

P / E

0.00
Anomalous

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-15.93
Highly reliable

Relative Strength

0 / 100
Severely lagging

Pre-Tax Margin

-369,865%
Severely loss-making

Business Description

Aditxt Inc. is a California-based company focused on developing tools and treatments that help people better understand and manage their immune systems. Its core offerings include a personal immune health monitoring system and a therapy designed to teach the body to tolerate its own tissues, reducing harmful immune responses. The company is also advancing treatments for conditions such as psoriasis, type 1 diabetes, and multiple sclerosis, supported by licensing agreements with two leading research universities.

Key Fundamentals

EPS25,450,142
P/E0.00
ROE926
RPS0.37
ROIC-66.12
ROA-245
Interest Cover-8.80
EBITDA, mln-50.69
EV / EBITDA-0.14
EV / EBIT-0.14
Revenue, mln0.01
EV / Revenue493

Quote Details

Last 0.0004
Change 0 (0%)
Open 0.0004
Volume 252,020
Turnover 100.81
Average Volume 8,268,465

Financial Ratios

Pre-Tax Profit Margin-369,865
Current Ratio0.06
Price / Sales27.85

Financial Strength

Altman Z-Score-35.84
Piotroski F-Score 2 / 9
Beneish M-Score-15.93
Short % of Float34.50

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 0% 52 / 100   
1 Month -88.24% 0 / 100   
2 Months -87.88% 1 / 100   
6 Months -99.99% 0 / 100   
1 Year -100% 0 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog